Markus Schulze
Research Subjects
Markus Schulze has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Rene H. Wijffels
Bioprocess Engineering Wageningen University Wageningen The Netherlands
3 shared publicationsDirk E. Martens
Bioprocess Engineering Wageningen University Wageningen The Netherlands
2 shared publications- Dirk E. Martens
Bioprocess Engineering, Wageningen University and Research, 6708PB Wageningen, The Netherlands
2 shared publications - Jens Matuszczyk
Sartorius Stedim Biotech GmbH, Germany
2 shared publications Julia Niemann
Corporate Research BioProcessing Upstream Sartorius Stedim Biotech GmbH Göttingen Germany
2 shared publicationsB R Müller
Institut für Strahlungs- und Kernphysik, Technische Universität Berlin, Hardenbergstr. 36, D-1000 Berlin 12, FRG
1 shared publication
Latest Publications
- Open Access
- 28 October 2022
- Published by Wiley in Chemie Ingenieur Technik
- Vol. 94 (12) , 1968-1976
Automation of Integrated Perfusion Control Simplifying Process Intensification of Mammalian Biomanufacturing in Single‐Use Bioreactors
Production of biopharmaceuticals needs to become faster, more flexible, and efficient. Perfusion processes allow to operate cell cultivations at higher cell concentrations, shorten their process time and increase their productivity. Still, either customized software solutions or third‐party stand‐alone control devices are often used for perfusion control. Its integration into a bioreactor automation platform will simplify the implementation and application of perfusion processes in the future. In this study, the automation of an integrated perfusion control strategy for a scalable single‐use bioreactor family is demonstrated. The control strategy is illustrated by means of a CHO cell N–1 perfusion process in a 50‐L bioreactor. Accurate control allowed to achieve 80 · 106 c mL−1 within five days. Furthermore, also DO and pH setpoints were precisely controlled throughout the N–1 perfusion process. Finally, the advantage of this process strategy is exemplified by comparing fed‐batch processes inoculated from N–1 perfusion vs. N–1 batch processes.
- 28 October 2022
- Published by Wiley in Chemie Ingenieur Technik
- Vol. 94 (12) , 1968-1976
Open AccessAutomation of Integrated Perfusion Control Simplifying Process Intensification of Mammalian Biomanufacturing in Single‐Use Bioreactors
Production of biopharmaceuticals needs to become faster, more flexible, and efficient. Perfusion processes allow to operate cell cultivations at higher cell concentrations, shorten their process time and increase their productivity. Still, either customized software solutions or third‐party stand‐alone control devices are often used for perfusion control. Its integration into a bioreactor automation platform will simplify the implementation and application of perfusion processes in the future. In this study, the automation of an integrated perfusion control strategy for a scalable single‐use bioreactor family is demonstrated. The control strategy is illustrated by means of a CHO cell N–1 perfusion process in a 50‐L bioreactor. Accurate control allowed to achieve 80 · 106 c mL−1 within five days. Furthermore, also DO and pH setpoints were precisely controlled throughout the N–1 perfusion process. Finally, the advantage of this process strategy is exemplified by comparing fed‐batch processes inoculated from N–1 perfusion vs. N–1 batch processes.
- Open Access
- 24 June 2022
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 119 (9) , 2359-2373
Transcriptomic analysis reveals mode of action of butyric acid supplementation in an intensified CHO cell fed‐batch process
Process intensification is increasingly used in the mammalian biomanufacturing industry. The key driver of this trend is the need for more efficient and flexible production strategies to cope with the increased demand for biotherapeutics predicted in the next years. Therefore, such intensified production strategies should be designed, established, and characterized. We established a CHO cell process consisting of an intensified fed‐batch (iFB), which is inoculated by an N‐1 perfusion process that reaches high cell concentrations (100 × 106 c ml−1). We investigated the impact of butyric acid (BA) supplementation in this iFB process. Most prominently, higher cellular productivities of more than 33% were achieved, thus 3.5 g L−1 of immunoglobulin G (IgG) was produced in 6.5 days. Impacts on critical product quality attributes were small. To understand the biological mechanisms of BA in the iFB process, we performed a detailed transcriptomic analysis. Affected gene sets reflected concurrent inhibition of cell proliferation and impact on histone modification. These translate into subsequently enhanced mechanisms of protein biosynthesis: enriched regulation of transcription, messenger RNA processing and transport, ribosomal translation, and cellular trafficking of IgG intermediates. Furthermore, we identified mutual tackling points for optimization by gene engineering. The presented strategy can contribute to meet future requirements in the continuously demanding field of biotherapeutics production.
- 24 June 2022
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 119 (9) , 2359-2373
Open AccessTranscriptomic analysis reveals mode of action of butyric acid supplementation in an intensified CHO cell fed‐batch process
Process intensification is increasingly used in the mammalian biomanufacturing industry. The key driver of this trend is the need for more efficient and flexible production strategies to cope with the increased demand for biotherapeutics predicted in the next years. Therefore, such intensified production strategies should be designed, established, and characterized. We established a CHO cell process consisting of an intensified fed‐batch (iFB), which is inoculated by an N‐1 perfusion process that reaches high cell concentrations (100 × 106 c ml−1). We investigated the impact of butyric acid (BA) supplementation in this iFB process. Most prominently, higher cellular productivities of more than 33% were achieved, thus 3.5 g L−1 of immunoglobulin G (IgG) was produced in 6.5 days. Impacts on critical product quality attributes were small. To understand the biological mechanisms of BA in the iFB process, we performed a detailed transcriptomic analysis. Affected gene sets reflected concurrent inhibition of cell proliferation and impact on histone modification. These translate into subsequently enhanced mechanisms of protein biosynthesis: enriched regulation of transcription, messenger RNA processing and transport, ribosomal translation, and cellular trafficking of IgG intermediates. Furthermore, we identified mutual tackling points for optimization by gene engineering. The presented strategy can contribute to meet future requirements in the continuously demanding field of biotherapeutics production.
- Open Access
- 29 September 2021
- Published by American Chemical Society (ACS)
Rapid CHO cell process intensification for mAb production: Implementation of an intensified fed-batch with doubled space-time yield
- 29 September 2021
- Published by American Chemical Society (ACS)
Open AccessRapid CHO cell process intensification for mAb production: Implementation of an intensified fed-batch with doubled space-time yield
- Open Access
- 20 September 2021
- Published by Wiley in Biotechnology Progress
- Vol. 38 (1) , e3213
Rapid intensification of an established CHO cell fed‐batch process
Currently, the mammalian biomanufacturing industry explores process intensification (PI) to meet upcoming demands of biotherapeutics while keeping production flexible but, more importantly, as economic as possible. However, intensified processes often require more development time compared with conventional fed-batches (FBs) preventing their implementation. Hence, rapid and efficient, yet straightforward strategies for PI are needed. In this study we demonstrate such a strategy for the intensification of an N-stage FB by implementing N-1 perfusion cell culture and high inoculum cell densities resulting in a robust intensified FB (iFB). Furthermore, we show successful combination of such an iFB with the addition of productivity enhancers, which has not been reported so far. The conventional CHO cell FB process was step-wise improved and intensified rapidly in multi-parallel small-scale bioreactors using N-1 perfusion. The iFBs were performed in 15 and 250 mL bioreactors and allowed to evaluate the impact on key process indicators (KPI): the space-time yield (STY) was successfully doubled from 0.28 to 0.55 g∙(L∙d)-1, while product quality was maintained. This gain was generated by initially increasing the inoculation density, thus shrinking process time, and secondly supplementation with butyric acid (BA), which reduced cell growth and enhanced cell-specific productivity from ~25 to 37 pg∙(cell∙d)-1. Potential impacts of PI on cell metabolism were evaluated using flux balance analysis. Initial metabolic differences between the standard and intensified process were observed but disappeared quickly. This shows that PI can be achieved rapidly for new as well as existing processes without introducing sustained changes in cellular and metabolic behavior.
- 20 September 2021
- Published by Wiley in Biotechnology Progress
- Vol. 38 (1) , e3213
Open AccessRapid intensification of an established CHO cell fed‐batch process
Currently, the mammalian biomanufacturing industry explores process intensification (PI) to meet upcoming demands of biotherapeutics while keeping production flexible but, more importantly, as economic as possible. However, intensified processes often require more development time compared with conventional fed-batches (FBs) preventing their implementation. Hence, rapid and efficient, yet straightforward strategies for PI are needed. In this study we demonstrate such a strategy for the intensification of an N-stage FB by implementing N-1 perfusion cell culture and high inoculum cell densities resulting in a robust intensified FB (iFB). Furthermore, we show successful combination of such an iFB with the addition of productivity enhancers, which has not been reported so far. The conventional CHO cell FB process was step-wise improved and intensified rapidly in multi-parallel small-scale bioreactors using N-1 perfusion. The iFBs were performed in 15 and 250 mL bioreactors and allowed to evaluate the impact on key process indicators (KPI): the space-time yield (STY) was successfully doubled from 0.28 to 0.55 g∙(L∙d)-1, while product quality was maintained. This gain was generated by initially increasing the inoculation density, thus shrinking process time, and secondly supplementation with butyric acid (BA), which reduced cell growth and enhanced cell-specific productivity from ~25 to 37 pg∙(cell∙d)-1. Potential impacts of PI on cell metabolism were evaluated using flux balance analysis. Initial metabolic differences between the standard and intensified process were observed but disappeared quickly. This shows that PI can be achieved rapidly for new as well as existing processes without introducing sustained changes in cellular and metabolic behavior.
- Open Access
- 4 June 2021
- Published by Elsevier in Journal of Biotechnology
- Vol. 335, 65-75
Automation of high CHO cell density seed intensification via online control of the cell specific perfusion rate and its impact on the N-stage inoculum quality
- 4 June 2021
- Published by Elsevier in Journal of Biotechnology
- Vol. 335, 65-75
Open AccessAutomation of high CHO cell density seed intensification via online control of the cell specific perfusion rate and its impact on the N-stage inoculum quality
- 9 November 1995
- Published by Institution of Engineering and Technology (IET) in Electronics Letters
- Vol. 31 (23) , 2008-2009
Fourier-transform-limited 2.5 ps light pulses withelectricallytunable wavelength (15 nm) by hybridly modelocking asemiconductor laser in a chirped Bragg grating fibre external cavity
A chirped Bragg grating fibre external cavity semiconductor laser is hybridly modelocked to generate light pulses with perfectly linear wavelength chirp, resulting in Fourier-transform-limited 2.5 ps pulses incorporated with subsequent chirp compensation. The setup facilitates wavelength tunability across the whole grating bandwidth (15 nm) by changing the modulation frequency.
- 9 November 1995
- Published by Institution of Engineering and Technology (IET) in Electronics Letters
- Vol. 31 (23) , 2008-2009
Fourier-transform-limited 2.5 ps light pulses withelectricallytunable wavelength (15 nm) by hybridly modelocking asemiconductor laser in a chirped Bragg grating fibre external cavity
A chirped Bragg grating fibre external cavity semiconductor laser is hybridly modelocked to generate light pulses with perfectly linear wavelength chirp, resulting in Fourier-transform-limited 2.5 ps pulses incorporated with subsequent chirp compensation. The setup facilitates wavelength tunability across the whole grating bandwidth (15 nm) by changing the modulation frequency.
- 1 January 1990
- Published by IOP Publishing in Physica Scripta
- Vol. T31, 28-31
Photoelectron Spectroscopy of Laser-Excited Aligned Free Atoms
The combined use of synchrotron and laser radiation for photoelectron spectroscopy of free atoms is described with special emphasis on the polarization of both radiation sources. By the absorption of the polarized laser radiation an atomic alignment or orientation is produced which has a strong influence on the subsequent absorption of the polarized synchrotron radiation and on the angular distribution of the photoelectrons.
- 1 January 1990
- Published by IOP Publishing in Physica Scripta
- Vol. T31, 28-31
Photoelectron Spectroscopy of Laser-Excited Aligned Free Atoms
The combined use of synchrotron and laser radiation for photoelectron spectroscopy of free atoms is described with special emphasis on the polarization of both radiation sources. By the absorption of the polarized laser radiation an atomic alignment or orientation is produced which has a strong influence on the subsequent absorption of the polarized synchrotron radiation and on the angular distribution of the photoelectrons.